Flagship Ventures Dives Into Microbiome, Launches Seres Health
19:46 EDT 27 Jun 2012 | Elsevier Business Intelligence
Only a few biopharmaceutical start-ups have formed in the emerging microbiome space, but VC firm Flagship says its homegrown Seres Health, still somewhat stealthy, is developing a new category of drugs that aim to rebalance microbiome populations cau..
Original Article: Flagship Ventures Dives Into Microbiome, Launches Seres Health
More From BioPortfolio on "Flagship Ventures Dives Into Microbiome, Launches Seres Health"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
